Keywords = Immunotherapy
Number of Articles: 23
Immunohistochemical Expression of PD-L1 and CTLA-4 in Triple Negative Breast Cancer and Their Prognostic Associations

Volume 26, Issue 1, January 2025, Pages 319-326

Nehal Moaz Mehrez; Dina Abdallah Ibrahim; Maha Esmail El-Zaafarany; Dina A. El-Tantawy; Azza Abdel-Aziz

Immunotherapy of Lung Cancer in Countries with Limited Resources; Current Challenges and Potential Solutions

Volume 25, Issue 8, August 2024, Pages 2583-2584

Arefeh Saeedian; Asghar Kazemzadeh; Seyed Alireza Javadinia

Immunotherapy and PD-L1 Tumor Expression in Moroccan Non-Small Cell Lung Cancer Patients with Various Metastasis

Volume 25, Issue 8, August 2024, Pages 2841-2852

Oussama Aazzane; Sofia Fathi; Meryeme Charkaoui; Abdelkader Acharki; Souha Sahraoui; Nadia Benchakroun; Hassan Fellah; Mehdi Karkouri

Immunohistochemical Expression of CD47 and CD68 in Breast Carcinoma and Their Prognostic Value

Volume 25, Issue 7, July 2024, Pages 2515-2527

Sara Alhanafy; Heba Hany; Khaled Nasef; Iman El-Salkh; Amira Elhawary

Clinicopathological Study of PD-1/PD-L1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with Emphasis on Large B-Cell Richter Transformation

Volume 24, Issue 12, December 2023, Pages 4243-4252

Rokia Masoud; Ahmed E Eladl; Shaimaa El-Ashwah; Ahmed Abbas; Wageeha Kandil

Evaluation of HHLA2 and CD8 Immunohistochemical Expression in Colorectal Carcinoma and Their Prognostic Significance

Volume 24, Issue 12, December 2023, Pages 4309-4319

Zeinab Mohammed Gawesh; Eman Mohamad Ibrahim; Hend Mohamed Hamdey Rashed ElKalla; Azmy Abdel Hamid Awad; Mie Ali Mohamed

Effect of Primary Systemic Therapy on PD-1, PD-L1, and PD-L2 mRNA Expression in Advanced Breast Cancer

Volume 22, Issue 7, July 2021, Pages 2069-2077

Ramadhan Karsono; Muhammad Al Azhar; Yulia Pratiwi; Fahreza Saputra; Siti Nadliroh; Teguh Aryandono

Human Endogenous Retrovirus-H Long Terminal Repeat- Associating Protein 2 (HHLA2) is a Novel Immune Checkpoint Protein in Lung Cancer which Predicts Survival

Volume 22, Issue 6, June 2021, Pages 1883-1889

Mayada Saad Farrag; Eman Mohamad Ibrahim; Tamer A. El-Hadidy; Mohamed Farouk Akl; Alyaa R. Elsergany; Heba Wagih Abdelwahab

Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung

Volume 22, Issue 2, February 2021, Pages 365-370

Takefumi Komiya; Neema Ravindra; Emily Powell

Programmed Death Ligand 1; An Immunotarget for Renal Cell Carcinoma

Volume 20, Issue 10, October 2019, Pages 2951-2957

Deepika Chandrasekaran; Sandhya Sundaram; Kadhiresan N; Padmavathi R

Programmed Death Ligand 1 (PD-L1) Expression in Epithelial Ovarian Cancer: A Comparison of Type I and Type II Tumors

Volume 20, Issue 4, April 2019, Pages 1161-1169

Wilasinee Nhokaew; Pilaiwan Kleebkaow; Nipon Chaisuriya; Chumnan Kietpeerakool

Increased Tumour Infiltration of CD4+ and CD8+ T-Lymphocytes in Patients with Triple Negative Breast Cancer Suggests Susceptibility to Immune Therapy

Volume 18, Issue 7, July 2017, Pages 1827-1832

Bushra Sikandar; Muhammad Asif Qureshi; Saima Naseem; Saeed Khan; Talat Mirza

Expression of Cancer-Testis Antigens in Pediatric Cancers

Volume 16, Issue 13, December 2015, Pages 5149-5152

Snake Venom: A Potent Anticancer Agent

Volume 13, Issue 10, October 2012, Pages 4855-4860

Asian Pacific Journal of Cancer Prevention

Journal Archive